Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 537 articles:
HTML format
Text format



Single Articles


    December 2018
  1. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247629. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. DEBRUYN JCC, Soon IS, Fonseca K, Feng S, et al
    Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247477. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. PABLA BS, Scoville EA, Sarker S, Dalal RL, et al
    Histoplasmosis as a Complication of Inflammatory Bowel Disease Therapy: A Case Series.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5244945. doi: 10.1093.
    PubMed     Text format    


  4. OBRAZTSOV IV, Shirokikh KE, Obraztsova OI, Shapina MV, et al
    Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5245415. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. SONG G, Fiocchi C, Achkar JP
    Acupuncture in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 11. pii: 5238704. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. YANG L, Tang S, Baker SS, Arijs I, et al
    Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.
    Inflamm Bowel Dis. 2018 Dec 4. pii: 5230141. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  7. PANHWAR MS, Mansoor E, Al-Kindi SG, Sinh P, et al
    Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.
    Inflamm Bowel Dis. 2018 Nov 30. pii: 5220868. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. MALDONADO FJ, Al Bawardy BF, Nehra AK, Lee YS, et al
    Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice.
    Inflamm Bowel Dis. 2018 Nov 27. pii: 5209842. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. FRIEDMAN S
    A Meta-analysis of Sexual Function in Patients With Inflammatory Bowel Disease: Examining a Small Piece of the Puzzle.
    Inflamm Bowel Dis. 2018 Nov 23. pii: 5203541. doi: 10.1093.
    PubMed     Text format    


  10. DIAB J, Al-Mahdi R, Gouveia-Figueira S, Hansen T, et al
    A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
    Inflamm Bowel Dis. 2018 Nov 22. pii: 5198657. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. SCAIOLI E, Belluzzi A
    Endoscopic and Histological Normalization as a Target to Prevent Clinical Relapse in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194185. doi: 10.1093.
    PubMed     Text format    


  12. OH SH, Sung YH, Kim I, Sim CK, et al
    Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 21. pii: 5194406. doi: 10.1093.
    PubMed     Text format     Abstract available



  13. Erratum to Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191226. doi: 10.1093.
    PubMed     Text format    


  14. VINAYAGA-PAVAN M, Frampton M, Pontikos N, Levine AP, et al
    Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5193210. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. KHERA AJ, Chase JW, Salzberg M, Thompson AJV, et al
    Gut-Directed Pelvic Floor Behavioral Treatment for Fecal Incontinence and Constipation in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 19. pii: 5191232. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. KELLY OB, Li N, Smith M, Chan J, et al
    The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 14. pii: 5183322. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. AHMED Z, Sarvepalli S, Garber A, Regueiro M, et al
    Value-Based Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 9. pii: 5168541. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Erratum to Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threatening Complication.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5167023. doi: 10.1093.
    PubMed     Text format    


  19. RAY G, Longworth MS
    Epigenetics, DNA Organization, and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 8. pii: 5166720. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. QAZI T, Farraye FA
    Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship.
    Inflamm Bowel Dis. 2018 Nov 2. pii: 5155657. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  21. FEAGAN BG, Schreiber S, Wolf DC, Axler JL, et al
    Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 25. pii: 5144762. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. SWAMINATH A, Berlin EP, Cheifetz A, Hoffenberg E, et al
    The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144402. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. GHERSIN I, Khateeb N, Katz LH, Daher S, et al
    Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144270. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. DROBIN K, Assadi G, Hong MG, Andersson E, et al
    Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci.
    Inflamm Bowel Dis. 2018 Oct 24. pii: 5144272. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. DE JONG DC, Lo Wenberg M, Koumoutsos I, Ray S, et al
    Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.
    Inflamm Bowel Dis. 2018 Oct 17. pii: 5134157. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. POUILLON L, Baumann C, Rousseau H, Choukour M, et al
    Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience.
    Inflamm Bowel Dis. 2018 Oct 16. pii: 5133439. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. KATSANOS KH, Saridi M, Albani E, Mantzouranis G, et al
    Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:2348-2349.
    PubMed     Text format    


  28. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Erratum to Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128779. doi: 10.1093.
    PubMed     Text format    


  29. LUKIN DJ, Lawlor G, Hudesman DP, Durbin L, et al
    Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5124548. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. MUNIZ PEDROGO DA, Chen J, Hillmann B, Jeraldo P, et al
    An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128781. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. EGBERG MD, Galanko JA, Barnes EL, Kappelman MD, et al
    Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 10. pii: 5126394. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. GRINDAL AW, Khan R, Scaffidi MA, Rumman A, et al
    Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120389. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. COTE-DAIGNEAULT J, Bessissow T, Nicolae MV, Nie R, et al
    Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120076. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. REINISCH W, Bressler B, Curtis R, Parikh A, et al
    Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5119830. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. TRAN L, Mulligan K
    A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117847. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. BATTAT R, Dulai PS, Vande Casteele N, Evans E, et al
    Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117434. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. GREENSTEIN R, Brown S
    A Data-Based Hypothesis That Inflammatory Bowel Disease Unclassified (IBD-U) May Indicate That IBD Is a Spectrum of a Single Infectious Intestinal Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5116939. doi: 10.1093.
    PubMed     Text format    


    September 2018
  38. FUKUDA T, Naganuma M, Sugimoto S, Ono K, et al
    Efficacy of Therapeutic Intervention for Patients With an Ulcerative Colitis Mayo Endoscopic Score of 1.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108467. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. SELINGER CP, Ochieng AO, George V, Leong RW, et al
    The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios.
    Inflamm Bowel Dis. 2018 Sep 27. pii: 5108473. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. SOLANKY D, Pardi DS, Loftus EV Jr, Khanna S, et al
    Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018 Sep 26. pii: 5107525. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. HABOUBI N
    Reporting Colonic Biopsies in Patients With Inflammatory Bowel Disease; a Practical Approach.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106751. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. MAO EJ, Sheibani S, Martin C, Bloomfeld RS, et al
    Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106752. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. KHANNA R, Vande Casteele N
    Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 25. pii: 5106774. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. KRUGER AJ, Hinton A, Afzali A
    Index Severity Score and Early Readmission Predicts Increased Mortality in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Sep 20. pii: 5104366. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. ZHENG C, Huang Y, Hu W, Shi J, et al
    Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 13. pii: 5096668. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. MINACAPELLI CD, Bajpai M, Geng X, Van Gurp J, et al
    miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094859. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. BORREN NZ, Khalili H, Luther J, Colizzo FP, et al
    Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2018 Sep 11. pii: 5094888. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. REICH J, Guo L, Groshek J, Weinberg J, et al
    Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Sep 7. pii: 5092671. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  49. JACKSON BD, De Cruz P
    Quality of Care in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086256. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. KAMAL A, Padival R, Lashner B
    Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.
    Inflamm Bowel Dis. 2018 Aug 29. pii: 5086585. doi: 10.1093.
    PubMed     Text format    


  51. AL-BAWARDY B, Ramos GP, Willrich MAV, Jenkins SM, et al
    Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079133. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. PEREZ-JELDRES T, Tyler CJ, Boyer JD, Karuppuchamy T, et al
    Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts.
    Inflamm Bowel Dis. 2018 Aug 24. pii: 5079145. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. FRITZ J, Walia C, Elkadri A, Pipkorn R, et al
    A Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 21. pii: 5077382. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. DAI C, Jiang M, Sun MJ
    The Effect of Smoking on the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074361. doi: 10.1093.
    PubMed     Text format    


  55. ISHIKAWA D, Sasaki T, Takahashi M, Kuwahara-Arai K, et al
    The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
    Inflamm Bowel Dis. 2018 Aug 14. pii: 5074053. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Response to the Letter to the Editor from Dai et al, Regarding "Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients with Ileal Pouch Anal Anastomosis".
    Inflamm Bowel Dis. 2018 Aug 13. pii: 5073207. doi: 10.1093.
    PubMed     Text format    


  57. NORGARD BM, Magnussen B, Fedder J, de Silva PS, et al
    The Risk of Elective Abortion in Women With Crohn's Disease and Ulcerative Colitis: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2018 Aug 10. pii: 5069528. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. AZUARA D, Ausso S, Rodriguez-Moranta F, Guardiola J, et al
    New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Aug 7. pii: 5067818. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. BERNARDO S, Fernandes SR, Goncalves AR, Valente A, et al
    Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067145. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. SITKIN S, Pokrotnieks J
    Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067149. doi: 10.1093.
    PubMed     Text format    


  61. GUADAGNO E, De Rosa F, Borrelli G, Luglio G, et al
    High-grade MiNEN in a Long-standing History of Ulcerative Colitis: An Unexpected Evolution.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067338. doi: 10.1093.
    PubMed     Text format    


  62. LYNCH B, Roberts A, Lee Grotz V
    Is Splenda, or Sucralose, Causally Linked to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067397. doi: 10.1093.
    PubMed     Text format    


  63. TEN HOVE JR, Bogaerts JMK, Bak MTJ, Lacle MM, et al
    Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 1. pii: 5063333. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  64. OUAHED J, Gordon W, Canavan JB, Zhou H, et al
    Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5062951. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. LAMBDIN JT, Borum M
    Cervical Cancer Screening in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5061940. doi: 10.1093.
    PubMed     Text format    


  66. WATT PJ, Irving MA
    A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2018 Jul 21. pii: 5056917. doi: 10.1093.
    PubMed     Text format    


  67. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055346. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. PORTER RJ, Andrews C, Brice DP, Durum SK, et al
    Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055343. doi: 10.1093.
    PubMed     Text format     Abstract available



  69. Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Jul 17. pii: 5054631. doi: 10.1093.
    PubMed     Text format    


  70. VOLK N, Siegel CA
    Defining Failure of Medical Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 16. pii: 5054534. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. TORMEY LK, Reich J, Chen YS, Singh A, et al
    Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 10. pii: 5051146. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050505. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. WREN AA, Bensen R, Sceats L, Dehghan M, et al
    Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050495. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. KUENZIG ME, Benchimol EI
    Chronic Opioid Use Among Youth With Inflammatory Bowel Disease: A New Approach Is Needed.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050494. doi: 10.1093.
    PubMed     Text format    


  75. REINISCH W, Colombel JF, Gibson PR, Rutgeerts P, et al
    Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
    Inflamm Bowel Dis. 2018 Jul 6. pii: 5049378. doi: 10.1093.
    PubMed     Text format     Abstract available



  76. Corrigendum to Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049267. doi: 10.1093.
    PubMed     Text format    


  77. KHAN N, Trivedi C, Kavani H, Lewis J, et al
    Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049271. doi: 10.1093.
    PubMed     Text format     Abstract available



  78. Corrigendum to Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049258. doi: 10.1093.
    PubMed     Text format    


  79. MAHADEVAN U, Dubinsky MC, Su C, Lawendy N, et al
    Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jul 2. pii: 5047917. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  80. SMITS LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, et al
    Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045878. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. SHIVASHANKAR R, Lichtenstein GR
    Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045858. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. XUE M, Shi L, Wang W, Chen S, et al
    An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.
    Inflamm Bowel Dis. 2018 Jun 25. pii: 5044833. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. DE SILVA PS, O'Toole A, Marc LG, Ulysse CA, et al
    Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 22. pii: 5042958. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threating Life Complication.
    Inflamm Bowel Dis. 2018 Jun 20. pii: 5040737. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. TAIDA T, Arai M, Fujie M, Akizue N, et al
    Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040214. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. PICORARO JA, Lee D, Heller CA, Weaver A, et al
    Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040260. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. BOSSUYT P, Baert F, D'Heygere F, Nakad A, et al
    Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038936. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. LEE CK, Melmed GY, Mann A, Danovitch I, et al
    A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038934. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. PHILPOTT JR, Kurowski JA
    Challenges in Transitional Care in Inflammatory Bowel Disease: A Review of the Current Literature in Transition Readiness and Outcomes.
    Inflamm Bowel Dis. 2018 Jun 11. pii: 5035657. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. SLONIM-NEVO V, Sarid O, Friger M, Schwartz D, et al
    Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018;24:1389-1400.
    PubMed     Text format     Abstract available


  91. TYLER CJ, Perez-Jeldres T, Ehinger E, Capaldo B, et al
    Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034710. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. WHITEOAK SR, Claridge A, Balendran CA, Harris RJ, et al
    MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034803. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. WHALEY KG, Rosen MJ
    Contemporary Medical Management of Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034511. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. RYAN E, McNicholas D, Creavin B, Kelly ME, et al
    Sarcopenia and Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034590. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. BLAZQUEZ ML, Hernani MT, Calatayud GA, Gonzalez-Pinto LC, et al
    Transition Care Program of Adolescents With Inflammatory Bowel Disease: Perceptions From A Survey for Patients.
    Inflamm Bowel Dis. 2018 Jun 5. pii: 5033090. doi: 10.1093.
    PubMed     Text format    


  96. ATREJA A
    Smarter Care for Patients With Inflammatory Bowel Disease: A Necessity for IBD Home, Value-Based Health Care and Treat-to-Target Strategies.
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032596. doi: 10.1093.
    PubMed     Text format    


  97. KELSO M, Feagins LA
    Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032595. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  98. ANDERSON A, Click B, Ramos-Rivers C, Koutroubakis IE, et al
    The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 31. pii: 5025926. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. WINTHROP KL, Melmed GY, Vermeire S, Long MD, et al
    Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025191. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. WIERSTRA K, Sutton R, Bal J, Ismond K, et al
    Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025410. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. CHANDRADEVAN R, Hofmekler T, Mondal K, Harun N, et al
    Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025792. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. ELIA J, Kane S
    Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise.
    Inflamm Bowel Dis. 2018 May 29. pii: 5020214. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. CHUDY-ONWUGAJE K, Abutaleb A, Buchwald A, Langenberg P, et al
    Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017268. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. KHANNA R, Narula N, Feagan BG
    The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017276. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. HOSOE N, Nakano M, Takeuchi K, Endo Y, et al
    Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 26. pii: 5011158. doi: 10.1093.
    PubMed     Text format     Abstract available


  106. BESSISSOW T, Dulai PS, Restellini S, Landry T, et al
    Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
    Inflamm Bowel Dis. 2018 May 25. pii: 5004810. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. SOFIA MA, Ciorba MA, Meckel K, Lim CK, et al
    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 22. pii: 5001501. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. PENG K, Qian X, Huang Z, Lu J, et al
    Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999329. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. SPAGNUOLO R, Dattilo V, D'Antona L, Cosco C, et al
    Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999450. doi: 10.1093.
    PubMed     Text format     Abstract available


  111. DORREEN A, Heisler C, Jones J
    Treatment of Inflammatory Bowel Disease in the Older Patient.
    Inflamm Bowel Dis. 2018;24:1155-1166.
    PubMed     Text format     Abstract available


  112. SZETO W, van der Bent A, Petty CR, Reich J, et al
    Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition.
    Inflamm Bowel Dis. 2018;24:1114-1122.
    PubMed     Text format     Abstract available


  113. SUH JH, Degagne E, Gleghorn EE, Setty M, et al
    Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Inflamm Bowel Dis. 2018;24:1321-1334.
    PubMed     Text format     Abstract available


  114. DIBLEY L, Czuber-Dochan W, Woodward S, Wade T, et al
    Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999398. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. KOPYLOV U, Verstockt B, Biedermann L, Sebastian S, et al
    Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999380. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. SHMIDT E, Kochhar G, Hartke J, Chilukuri P, et al
    Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999184. doi: 10.1093.
    PubMed     Text format     Abstract available


  117. MITCHELL NE, Harrison N, Junga Z, Singla M, et al
    Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999386. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. KHANNA R, Zou G, Feagan BG
    Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999190. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. ZHANG M, Merlin D
    Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999330. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. ABUTALEB A, Buchwald A, Chudy-Onwugaje K, Langenberg P, et al
    Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999387. doi: 10.1093.
    PubMed     Text format     Abstract available


  121. MERKER AM, Riaz M, Friedman S, Allegretti JR, et al
    Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999337. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. BARNES EL, Kochar B, Long MD, Pekow J, et al
    Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999440. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. NAVABI S, Gorrepati VS, Yadav S, Chintanaboina J, et al
    Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999008. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. HARTMAN DJ, Binion DG, Regueiro MD, Miller C, et al
    Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998978. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. YUNG DE, Horesh N, Lightner AL, Ben-Horin S, et al
    Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998839. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. LIU R, Tang A, Wang X, Shen S, et al
    Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999056. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. ZHENG C, Huang Y, Ye Z, Wang Y, et al
    Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
    Inflamm Bowel Dis. 2018 May 17. pii: 4999659. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. HEMPERLY A, Sandborn WJ, Vande Casteele N
    Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998913. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. KOSLOWSKY B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, et al
    Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998813. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. AL-AMODI O, Jodeleit H, Beigel F, Wolf E, et al
    CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998980. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. RESTELLINI S, Khanna R, Afif W
    Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999007. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999006. doi: 10.1093.
    PubMed     Text format     Abstract available


  133. DAI C, Jiang M, Sun MJ
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999019. doi: 10.1093.
    PubMed     Text format    


  134. MOTTA JP, Allain T, Green-Harrison LE, Groves RA, et al
    Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4997020. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. MADSEN KG, Pottegard A, Hallas J, Kjeldsen J, et al
    Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998912. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. COLOMBEL JF
    Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998802. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. LIGHTNER AL
    A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999009. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. JIAN L, Anqi H, Gang L, Litian W, et al
    Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996921. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. ROBERTS RL, Wallace MC, Seinen ML, van Bodegraven AA, et al
    Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996867. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. LI L, Huang S, Wang H, Chao K, et al
    Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996911. doi: 10.1093.
    PubMed     Text format     Abstract available


  141. WEIMERS P, Halfvarson J, Sachs MC, Saunders-Pullman R, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996912. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. BEGGS AD, James J, Caldwell G, Prout T, et al
    Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
    Inflamm Bowel Dis. 2018 May 14. pii: 4995684. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. BIANCARDI AL, Zaltman C, Troncoso LL, Luiz RR, et al
    The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 11. pii: 4995039. doi: 10.1093.
    PubMed     Text format    


  144. MOON CM, Kim SW, Ahn JB, Ma HW, et al
    Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.
    Inflamm Bowel Dis. 2018 May 4. pii: 4992873. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. ROBLIN X, Riviere P, Flamant M, Veyrard P, et al
    Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 3. pii: 4992140. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. WENG MT, Park SH, Matsuoka K, Tung CC, et al
    Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Inflamm Bowel Dis. 2018 May 3. pii: 4991928. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. BARBER GE, Hendler S, Okafor P, Limsui D, et al
    Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Inflamm Bowel Dis. 2018 May 2. pii: 4990922. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  148. OKABAYASHI S, Kobayashi T, Nakano M, Toyonaga T, et al
    A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990576. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. SPENCER EA, Davis SM, Mack DR, Boyle BM, et al
    Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990334. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. THEODORAKI E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990625. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. LEWIS JD
    Inflammatory Bowel Disease Care: What to Do When There Is a Breach of Contract between the Patient and Physician?
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990352. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. BURKE KE, Khalili H, Garber JJ, Haritunians T, et al
    Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990575. doi: 10.1093.
    PubMed     Text format     Abstract available


  153. PATIL SA, Cross RK
    Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 28. pii: 4989997. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. WU B, Wang Z, Zhang Q
    Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 27. pii: 4989472. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. CHI LY, Zitomersky NL, Liu E, Tollefson S, et al
    The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987131. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. KATSANOS KH, Kyriakidi K, Skamnelos A, Christodoulou DK, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4990626. doi: 10.1093.
    PubMed     Text format    


  157. RAMOS GP, Stroh G, Al-Bawardy B, Faubion WA, et al
    Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987150. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. DIEDEREN K, Krom H, Koole JCD, Benninga MA, et al
    Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985538. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. GREENER T, Kabakchiev B, Hillary Steinhart A, Silverberg MS, et al
    Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985513. doi: 10.1093.
    PubMed     Text format     Abstract available


  160. KHAN N, Trivedi C, Shah Y, Cole E, et al
    The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985719. doi: 10.1093.
    PubMed     Text format     Abstract available


  161. DANESE S, D'Amico F, Bonovas S, Peyrin-Biroulet L, et al
    Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985510. doi: 10.1093.
    PubMed     Text format     Abstract available


  162. LEGA S, Dubinsky MC
    What Are the Targets of Inflammatory Bowel Disease Management.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985529. doi: 10.1093.
    PubMed     Text format     Abstract available


  163. BERINSTEIN JA, Waljee AK, Stidham RW, Higgins PDR, et al
    The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e18.
    PubMed     Text format    


  164. CHIBA M, Sugawara T, Komatsu M, Tozawa H, et al
    Onset of Ulcerative Colitis in the Second Trimester after Emesis Gravidarum: Treatment with Plant-based Diet.
    Inflamm Bowel Dis. 2018;24:e8-e9.
    PubMed     Text format    


  165. ROLLI V, Macquin C, Kokten T, Hablot J, et al
    Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e10.
    PubMed     Text format    


  166. KOCHHAR G, Steele S, Sanaka M, Gorgun E, et al
    Endoscopic Submucosal Dissection for Flat Colonic Polyps in Patients With Inflammatory Bowel Disease, A Single-Center Experience.
    Inflamm Bowel Dis. 2018;24:e14-e15.
    PubMed     Text format    


  167. SHERMAN HOREV H, Rabinowitz KM, Elad H, Barkan R, et al
    Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
    Inflamm Bowel Dis. 2018;24:1045-1054.
    PubMed     Text format     Abstract available


  168. SULLIVAN SN
    Bullous Pyoderma Gangrenosum and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e16-e17.
    PubMed     Text format    


  169. GAMWELL KL, Baudino MN, Bakula DM, Sharkey CM, et al
    Perceived Illness Stigma, Thwarted Belongingness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2018;24:960-965.
    PubMed     Text format     Abstract available


  170. YE L, Jiang Z, Liu J, Zhou W, et al
    Is There a New Classification of Inflammatory Bowel Disease (IBD)-Adult-Onset Mixed IBD.
    Inflamm Bowel Dis. 2018;24:e19-e20.
    PubMed     Text format    


  171. KNOWLES SR, Keefer L, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.
    Inflamm Bowel Dis. 2018;24:966-976.
    PubMed     Text format     Abstract available


  172. BETTNER W, Rizzo A, Brant S, Dudley-Brown S, et al
    Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.
    Inflamm Bowel Dis. 2018;24:1092-1098.
    PubMed     Text format     Abstract available


  173. MARIABEATRICE P, Andrea I, Giuseppe L, Michela M, et al
    Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Inflamm Bowel Dis. 2018 Apr 23. pii: 4982709. doi: 10.1093.
    PubMed     Text format     Abstract available


  174. SEVERS M, Spekhorst LM, Mangen MJ, Dijkstra G, et al
    Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.
    Inflamm Bowel Dis. 2018 Apr 21. pii: 4980986. doi: 10.1093.
    PubMed     Text format     Abstract available


  175. AKHUEMONKHAN E, Parian A, Carson KA, Hutfless S, et al
    Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969822. doi: 10.1093.
    PubMed     Text format     Abstract available


  176. MEIJER B, Mulder CJJ, Bouma G, Ponsioen CY, et al
    Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969999. doi: 10.1093.
    PubMed     Text format     Abstract available


  177. AUTH MK, Bunn SK, Protheroe AL, Williams LJ, et al
    Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969914. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. GULATI S, Emmanuel A, Burt M, Dubois P, et al
    Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: a Single United Kingdom Center Experience.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969983. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. SHUTKEVER O, Gracie DJ, Young C, Wood HM, et al
    No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4970060. doi: 10.1093.
    PubMed     Text format     Abstract available


  180. CARD T, Xu J, Liang H, Bhayat F, et al
    What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab?
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969878. doi: 10.1093.
    PubMed     Text format     Abstract available


  181. HOSOMI S, Watanabe K, Nishida Y, Yamagami H, et al
    Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969863. doi: 10.1093.
    PubMed     Text format     Abstract available


  182. VAN DE VONDEL S, Baert F, Reenaers C, Vanden Branden S, et al
    Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969974. doi: 10.1093.
    PubMed     Text format     Abstract available


  183. FLYNN AD, Valentine JF
    Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969996. doi: 10.1093.
    PubMed     Text format     Abstract available


  184. WENTWORTH BJ, Buerlein RCD, Tuskey AG, Overby MA, et al
    Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969742. doi: 10.1093.
    PubMed     Text format     Abstract available


  185. DUBINSKY MC, Cross RK, Sandborn WJ, Long M, et al
    Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969986. doi: 10.1093.
    PubMed     Text format     Abstract available


  186. BERNSTEIN CN, Zhang L, Lix LM, Graff LA, et al
    The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969741. doi: 10.1093.
    PubMed     Text format     Abstract available


  187. MARK-CHRISTENSEN A, Laurberg S, Haboubi N
    Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969836. doi: 10.1093.
    PubMed     Text format     Abstract available


  188. BUER LCT, Hoivik ML, Warren DJ, Medhus AW, et al
    Combining Anti-TNF-alpha and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series.
    Inflamm Bowel Dis. 2018 Apr 12. pii: 4969708. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  189. GU P, Kuenzig ME, Kaplan GG, Pimentel M, et al
    Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Mar 30. pii: 4916092. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. DE SOUZA HSP, Fiocchi C
    Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:671-679.
    PubMed     Text format     Abstract available


  191. KNOWLES SR, Graff LA, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.
    Inflamm Bowel Dis. 2018;24:742-751.
    PubMed     Text format     Abstract available


  192. VENKATESWARAN S, Prince J, Cutler DJ, Marigorta UM, et al
    Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:829-838.
    PubMed     Text format     Abstract available


  193. LEE WJ, Lee TA, Calip GS, Suda KJ, et al
    Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:883-891.
    PubMed     Text format     Abstract available


  194. CHRISTENSEN B, Colman RJ, Micic D, Gibson PR, et al
    Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
    Inflamm Bowel Dis. 2018;24:849-860.
    PubMed     Text format     Abstract available


  195. VORTIA E, Uko VE, Yen-Lieberman B, Frawley J, et al
    Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Inflamm Bowel Dis. 2018;24:877-882.
    PubMed     Text format     Abstract available


  196. IRVING PM, Iqbal T, Nwokolo C, Subramanian S, et al
    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 10. pii: 4925788. doi: 10.1093.
    PubMed     Text format     Abstract available


  197. SHIRAI S, Hara M, Sakata Y, Tsuruoka N, et al
    Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2018 Mar 9. pii: 4925593. doi: 10.1093.
    PubMed     Text format     Abstract available


  198. MOUCHLI MA, Singh S, Boardman L, Bruining DH, et al
    Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924363. doi: 10.1093.
    PubMed     Text format     Abstract available


  199. AARDOOM MA, Linda Joosse ME, de Vries ACH, Levine A, et al
    Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924482. doi: 10.1093.
    PubMed     Text format     Abstract available


  200. MARQUES DA COSTA P, Correia L, Correia LA
    The Complexity of Renal Involvment in IBD-C3 Glomerulopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924366. doi: 10.1093.
    PubMed     Text format    


  201. LITSTER B, Bernstein CN, Graff LA, Walker JR, et al
    Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924383. doi: 10.1093.
    PubMed     Text format     Abstract available


  202. KHAN N, Trivedi C, Shah Y, Patel D, et al
    The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924495. doi: 10.1093.
    PubMed     Text format     Abstract available


  203. LIGHTNER AL, Mathis KL, Tse CS, Pemberton JH, et al
    Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Mar 2. pii: 4917693. doi: 10.1093.
    PubMed     Text format     Abstract available


  204. DANION P, Buisson A, Roblin X, Mathieu N, et al
    IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916100. doi: 10.1093.
    PubMed     Text format     Abstract available


  205. PATEL P, Yarur A, Dalal S, Sakuraba A, et al
    Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916098. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  206. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Feb 28. pii: 4913664. doi: 10.1093.
    PubMed     Text format     Abstract available


  207. DA SILVA S, Keita AV, Mohlin S, Pahlman S, et al
    A Novel Topical PPARgamma Agonist Induces PPARgamma Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909417. doi: 10.1093.
    PubMed     Text format     Abstract available


  208. REZAIE A, Gu P, Kaplan GG, Pimentel M, et al
    Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909412. doi: 10.1093.
    PubMed     Text format     Abstract available


  209. ZAMORA C, Canto E, Nieto JC, Garcia-Planella E, et al
    Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Feb 23. pii: 4908015. doi: 10.1093.
    PubMed     Text format     Abstract available


  210. KATSANOS KH, Papamichael K, Cheifetz AS, Christodoulou DK, et al
    Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:465-466.
    PubMed     Text format    


  211. UHLIG HH
    Mendelian Diseases and Inflammatory Bowel Disease-Data Mining for Genetic Risk and Disease-Associated Confounders.
    Inflamm Bowel Dis. 2018;24:467-470.
    PubMed     Text format    


  212. HAN L, Maciejewski M, Brockel C, Afzelius L, et al
    Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:471-481.
    PubMed     Text format     Abstract available


  213. FIORINO G, Ruiz-Arguello MB, Maguregui A, Nagore D, et al
    Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:601-606.
    PubMed     Text format     Abstract available


  214. EWELUKWA O, Perez R, Carter LE, Fernandez A, et al
    Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity.
    Inflamm Bowel Dis. 2018;24:552-557.
    PubMed     Text format     Abstract available


  215. DE ANGELIS PM, Schjolberg AR, Hughes JB, Huitfeldt HS, et al
    Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
    Inflamm Bowel Dis. 2018;24:593-600.
    PubMed     Text format     Abstract available


  216. BHANDARI S, Saeian K, Stein D
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:661.
    PubMed     Text format    


  217. DAI C, Cao Q, Sun MJ
    Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:662.
    PubMed     Text format    


  218. ZHOU F, Hamza T, Fleur AS, Zhang Y, et al
    Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Inflamm Bowel Dis. 2018;24:573-582.
    PubMed     Text format     Abstract available


  219. SAUER CG, Loop MS, Venkateswaran S, Tangpricha V, et al
    Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naive Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:641-650.
    PubMed     Text format     Abstract available


  220. OPSTELTEN JL, Chan SSM, Hart AR, van Schaik FDM, et al
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.
    Inflamm Bowel Dis. 2018;24:633-640.
    PubMed     Text format     Abstract available


  221. NORDENVALL C, Olen O, Johan Nilsson P, Ekbom A, et al
    Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy.
    Inflamm Bowel Dis. 2018;24:624-632.
    PubMed     Text format     Abstract available


  222. SHAH SC, Naymagon S, Panchal HJ, Sands BE, et al
    Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2018;24:651-659.
    PubMed     Text format     Abstract available


  223. GONCALVES P, Araujo JR, Di Santo JP
    A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:558-572.
    PubMed     Text format     Abstract available


    January 2018
  224. KANG B, Lee Y, Lee K, Choi YO, et al
    Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829375. doi: 10.1093.
    PubMed     Text format     Abstract available


  225. MOSHER CA, Brown GR, Weideman RA, Crook TW, et al
    Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829349. doi: 10.1093.
    PubMed     Text format     Abstract available


  226. RAO BB, Lashner B, Kowdley KV
    Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Trasnplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018;24:269-276.
    PubMed     Text format     Abstract available


  227. O'TOOLE A, de Silva PS, Marc LG, Ulysse CA, et al
    Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.
    Inflamm Bowel Dis. 2018;24:310-316.
    PubMed     Text format     Abstract available


  228. HUGUET M, Pereira B, Goutte M, Goutorbe F, et al
    Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:261-268.
    PubMed     Text format     Abstract available


  229. SCOTT FI, Shah Y, Lasch K, Luo M, et al
    Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model.
    Inflamm Bowel Dis. 2018;24:286-295.
    PubMed     Text format     Abstract available


  230. YARLAS A, D'Haens G, Willian MK, Teynor M, et al
    Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Inflamm Bowel Dis. 2018;24:450-463.
    PubMed     Text format     Abstract available


  231. LARSEN L, Drewes AM, Broberg MCH, Fallingborg J, et al
    Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Inflamm Bowel Dis. 2018;24:433-439.
    PubMed     Text format     Abstract available


  232. PIESTER T, Frymoyer A, Christofferson M, Yu H, et al
    A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:227-234.
    PubMed     Text format     Abstract available


  233. GOYAL A, Yeh A, Bush BR, Firek BA, et al
    Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:410-421.
    PubMed     Text format     Abstract available


  234. HABERMAN Y, BenShoshan M, Di Segni A, Dexheimer PJ, et al
    Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Inflamm Bowel Dis. 2018;24:346-360.
    PubMed     Text format     Abstract available


  235. MACALUSO FS, Sapienza C, Ventimiglia M, Renna S, et al
    The Addition of an Immunosuppressant After Loss of Response to Anti-TNFalpha Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
    Inflamm Bowel Dis. 2018;24:394-401.
    PubMed     Text format     Abstract available


  236. ROLSTON VS, Boroujerdi L, Long MD, McGovern DPB, et al
    The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.
    Inflamm Bowel Dis. 2018;24:387-393.
    PubMed     Text format     Abstract available


  237. PRATT PK JR, David N, Weber HC, Little FF, et al
    Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Inflamm Bowel Dis. 2018;24:380-386.
    PubMed     Text format     Abstract available


    December 2017
  238. BAKER DM, Lee MJ, Jones GL, Brown SR, et al
    The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.
    Inflamm Bowel Dis. 2017;24:179-190.
    PubMed     Text format     Abstract available


  239. VAN GENNEP S, de Boer NK, D'Haens GR, Lowenberg M, et al
    Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    Inflamm Bowel Dis. 2017;24:67-77.
    PubMed     Text format     Abstract available


  240. GROSSBERG LB, Papamichael K, Feuerstein JD, Siegel CA, et al
    A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;24:191-197.
    PubMed     Text format     Abstract available


  241. KELSO M, Weideman RA, Cipher DJ, Feagins LA, et al
    Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare.
    Inflamm Bowel Dis. 2017;24:5-11.
    PubMed     Text format     Abstract available


  242. VAJRAVELU RK, Osterman MT, Aberra FN, Roy JA, et al
    Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
    Inflamm Bowel Dis. 2017;24:217-226.
    PubMed     Text format     Abstract available


  243. AFZALI A, Ciorba MA, Schwartz DA, Sharaf M, et al
    Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
    Inflamm Bowel Dis. 2017;24:2-4.
    PubMed     Text format     Abstract available


  244. HUNDORFEAN G, Chiriac MT, Mihai S, Hartmann A, et al
    Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2017;24:35-44.
    PubMed     Text format     Abstract available


  245. DI RUSCIO M, Vernia F, Ciccone A, Frieri G, et al
    Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Inflamm Bowel Dis. 2017;24:78-92.
    PubMed     Text format     Abstract available


  246. NETZ U, Carter J, Eichenberger MR, Feagins K, et al
    Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;24:159-165.
    PubMed     Text format     Abstract available


  247. MYKLEBUST-HANSEN T, Aamodt G, Haugen M, Brantsaeter AL, et al
    Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).
    Inflamm Bowel Dis. 2017;24:12-24.
    PubMed     Text format     Abstract available


  248. MARCHIONI BEERY RM, Barnes EL, Nadkarni A, Korzenik JR, et al
    Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
    Inflamm Bowel Dis. 2017;24:25-34.
    PubMed     Text format     Abstract available


  249. WALJEE AK, Lipson R, Wiitala WL, Zhang Y, et al
    Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
    Inflamm Bowel Dis. 2017;24:45-53.
    PubMed     Text format     Abstract available


  250. HYAMS JS, Chan D, Adedokun OJ, Padgett L, et al
    Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
    Inflamm Bowel Dis. 2017;23:2227-2237.
    PubMed     Text format     Abstract available


  251. BARNES EL, Kochar B, Long MD, Martin CF, et al
    Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.
    Inflamm Bowel Dis. 2017;23:2189-2196.
    PubMed     Text format     Abstract available


  252. YE Z, Zhou Y, Huang Y, Wang Y, et al
    Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
    Inflamm Bowel Dis. 2017;23:2154-2164.
    PubMed     Text format     Abstract available


  253. EL-MATARY W, Dykes DMH, Bauman L, Elkadri A, et al
    Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    Inflamm Bowel Dis. 2017;23:2104-2108.
    PubMed     Text format     Abstract available


  254. SELINGER CP, Lenti MV, Clark T, Rafferty H, et al
    Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2083-2088.
    PubMed     Text format     Abstract available


  255. ARSENEAU KKO, Cominelli F
    Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2069-2071.
    PubMed     Text format    


    November 2017
  256. SHIBATA W, Sohara M, Wu R, Kobayashi K, et al
    Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.
    Inflamm Bowel Dis. 2017;23:2042-2047.
    PubMed     Text format     Abstract available


  257. HOPKINS CWP
    Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination.
    Inflamm Bowel Dis. 2017;23:E54.
    PubMed     Text format    


    October 2017
  258. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Text format     Abstract available


  259. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Text format     Abstract available


  260. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Text format     Abstract available


  261. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 20. doi: 10.1097/MIB.0000000000001277.
    PubMed     Text format     Abstract available


  262. CONRAD MA, Dawany N, Sullivan KE, Devoto M, et al
    Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 11. doi: 10.1097/MIB.0000000000001280.
    PubMed     Text format     Abstract available


  263. PONTE A, Pinho R, Fernandes S, Rodrigues A, et al
    Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001275.
    PubMed     Text format     Abstract available


  264. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001236.
    PubMed     Text format     Abstract available


  265. SO J, Tang W, Leung WK, Li M, et al
    Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001240.
    PubMed     Text format     Abstract available


  266. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed     Text format    


  267. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed     Text format    


  268. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Text format     Abstract available


  269. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Text format     Abstract available


  270. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Text format     Abstract available


  271. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Text format     Abstract available


    September 2017
  272. KRAWIEC P, Mroczkowska-Juchkiewicz A, Pac-Kozuchowska E
    Serum Hepcidin in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001245.
    PubMed     Text format     Abstract available


  273. ROBLIN X, Boschetti G, Duru G, Williet N, et al
    Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001223.
    PubMed     Text format     Abstract available


  274. PETERSEN BS, August D, Abt R, Alddafari M, et al
    Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.
    Inflamm Bowel Dis. 2017 Sep 19. doi: 10.1097/MIB.0000000000001235.
    PubMed     Text format     Abstract available


  275. NGUYEN VQ, Jiang D, Hoffman SN, Guntaka S, et al
    Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001257.
    PubMed     Text format     Abstract available


  276. VANCAMELBEKE M, Vanuytsel T, Farre R, Verstockt S, et al
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001246.
    PubMed     Text format     Abstract available


  277. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E47.
    PubMed     Text format    


  278. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E46-E47.
    PubMed     Text format    


  279. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017;23:1510-1515.
    PubMed     Text format     Abstract available


  280. TANG MS, Bowcutt R, Leung JM, Wolff MJ, et al
    Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
    Inflamm Bowel Dis. 2017;23:1544-1554.
    PubMed     Text format     Abstract available


    August 2017
  281. ALLEGRETTI J, Eysenbach LM, El-Nachef N, Fischer M, et al
    The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001247.
    PubMed     Text format     Abstract available


  282. LIGHTNER AL, McKenna NP, Moncrief S, Pemberton JH, et al
    Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001248.
    PubMed     Text format     Abstract available


  283. KONIJETI GG, Kim N, Lewis JD, Groven S, et al
    Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001221.
    PubMed     Text format     Abstract available


  284. KAMMERLANDER H, Nielsen J, Knudsen T, Kjeldsen J, et al
    Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001234.
    PubMed     Text format     Abstract available


  285. MUDIREDDY P, Scott F, Feathers A, Lichtenstein GR, et al
    Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001242.
    PubMed     Text format     Abstract available


  286. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001239.
    PubMed     Text format    


  287. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001228.
    PubMed     Text format     Abstract available


  288. HYAMS JS, Kugathasan S, Dubinsky MC
    Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001206.
    PubMed     Text format    


  289. CHRISTIAN KE, Jambaulikar GD, Hagan MN, Syed AM, et al
    Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001213.
    PubMed     Text format     Abstract available


  290. GOLD SL, Cohen-Mekelburg S, Schneider Y, Shen N, et al
    Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001189.
    PubMed     Text format     Abstract available


  291. BHANDARI S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, et al
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001218.
    PubMed     Text format     Abstract available


  292. CHENG J, Hamilton Z, Smyth M, Barker C, et al
    Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001212.
    PubMed     Text format     Abstract available


  293. LU Y, Zamora-Ros R, Chan S, Cross AJ, et al
    Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001108.
    PubMed     Text format     Abstract available


  294. LI SX, Thompson KD, Peterson T, Huneven S, et al
    Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001210.
    PubMed     Text format     Abstract available


  295. BRAMUZZO M, Stocco G, Montico M, Arrigo S, et al
    Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001195.
    PubMed     Text format     Abstract available


  296. KLAG T, Mazurak N, Fantasia L, Schwille-Kiuntke J, et al
    High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001216.
    PubMed     Text format     Abstract available


  297. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001229.
    PubMed     Text format    


  298. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001225.
    PubMed     Text format    


  299. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001231.
    PubMed     Text format     Abstract available


  300. ISAKOV O, Dotan I, Ben-Shachar S
    Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 8. doi: 10.1097/MIB.0000000000001222.
    PubMed     Text format     Abstract available


  301. MARIN-JIMENEZ I, Gobbo Montoya M, Panadero A, Canas M, et al
    Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project.
    Inflamm Bowel Dis. 2017 Aug 3. doi: 10.1097/MIB.0000000000001205.
    PubMed     Text format     Abstract available


  302. PEPE J, Zawadynski S, Herrmann FR, Juillerat P, et al
    Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).
    Inflamm Bowel Dis. 2017;23:1410-1417.
    PubMed     Text format     Abstract available


  303. JOLVING LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, et al
    The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2017;23:1440-1446.
    PubMed     Text format     Abstract available


  304. SUN C, Zhao Y, Gao X, Yuan Y, et al
    Cideb Deficiency Aggravates Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice by Exacerbating the Oxidative Burden in Colonic Mucosa.
    Inflamm Bowel Dis. 2017;23:1338-1347.
    PubMed     Text format     Abstract available


  305. AL-DARMAKI A, Hubbard J, Seow CH, Leung Y, et al
    Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:1272-1277.
    PubMed     Text format     Abstract available


  306. TIAO DK, Chan W, Jeganathan J, Chan JT, et al
    Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1257-1261.
    PubMed     Text format     Abstract available


    July 2017
  307. BAKER DM, Marshall JH, Lee MJ, Jones GL, et al
    A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001198.
    PubMed     Text format     Abstract available


  308. COHN HM, Dave M, Loftus EV Jr
    Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001199.
    PubMed     Text format     Abstract available


  309. AGUAS PERIS M, Boso V, Navarro B, Marques-Minana MR, et al
    Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001182.
    PubMed     Text format     Abstract available


  310. MARTIN T, Smukalla SM, Kane S, Hudesman DP, et al
    Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001186.
    PubMed     Text format     Abstract available


  311. VOSKENS CJ, Fischer A, Roessner S, Lorenz C, et al
    Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001192.
    PubMed     Text format     Abstract available


  312. SYED S, Michalski ES, Tangpricha V, Chesdachai S, et al
    Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001178.
    PubMed     Text format     Abstract available


  313. SEVERS M, Mangen MJ, Fidder HH, van der Valk ME, et al
    Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001201.
    PubMed     Text format     Abstract available


  314. MATSUNO H, Kayama H, Nishimura J, Sekido Y, et al
    CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001204.
    PubMed     Text format     Abstract available


  315. STARK CM, Gorman GH, Nylund CM
    Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients.
    Inflamm Bowel Dis. 2017 Jul 10. doi: 10.1097/MIB.0000000000001188.
    PubMed     Text format     Abstract available


  316. ROBER N, Noss L, Goihl A, Reinhold D, et al
    Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 6. doi: 10.1097/MIB.0000000000001159.
    PubMed     Text format     Abstract available


  317. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Text format     Abstract available


  318. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Text format     Abstract available


    June 2017
  319. TAXONERA C, Rodriguez C, Bertoletti F, Menchen L, et al
    Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 30. doi: 10.1097/MIB.0000000000001144.
    PubMed     Text format     Abstract available


  320. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Text format     Abstract available


  321. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Text format     Abstract available


  322. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Text format     Abstract available


  323. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Text format     Abstract available


  324. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Text format     Abstract available


  325. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Text format     Abstract available


  326. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Text format     Abstract available


  327. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Text format     Abstract available


  328. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Text format     Abstract available


  329. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Text format     Abstract available


  330. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Text format     Abstract available


  331. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Text format     Abstract available


  332. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Text format     Abstract available


  333. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed     Text format    


  334. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed     Text format    


    May 2017
  335. DAN A, Boutros M, Nedjar H, Kopylov U, et al
    Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2017 May 29. doi: 10.1097/MIB.0000000000001147.
    PubMed     Text format     Abstract available


  336. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Text format     Abstract available


  337. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Text format     Abstract available


  338. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Text format     Abstract available


  339. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Text format     Abstract available


  340. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Text format     Abstract available


  341. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Text format     Abstract available


  342. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Text format     Abstract available


  343. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Text format     Abstract available


  344. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Text format     Abstract available


  345. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Text format     Abstract available


  346. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Text format     Abstract available


  347. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Text format     Abstract available


  348. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Text format     Abstract available


  349. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Text format     Abstract available


  350. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Text format     Abstract available


  351. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Text format     Abstract available


  352. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Text format     Abstract available


  353. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Text format     Abstract available


  354. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Text format     Abstract available


  355. ASSA A, Bronsky J, Kolho KL, Zarubova K, et al
    Anti-TNFalpha Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure.
    Inflamm Bowel Dis. 2017;23:791-797.
    PubMed     Text format     Abstract available


  356. DOTSON JL, Cho M, Bricker J, Kappelman MD, et al
    Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network.
    Inflamm Bowel Dis. 2017;23:767-774.
    PubMed     Text format     Abstract available


  357. BROCHARD C, Siproudhis L, Leveque J, Grouin A, et al
    Factors Associated with Fecal Incontinence in Women of Childbearing Age with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:775-780.
    PubMed     Text format     Abstract available


  358. MA C, Fedorak RN, Kaplan GG, Dieleman LA, et al
    Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
    Inflamm Bowel Dis. 2017;23:833-839.
    PubMed     Text format     Abstract available


  359. WILSON A, Tirona RG, Kim RB
    CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:804-813.
    PubMed     Text format     Abstract available


    April 2017
  360. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Text format     Abstract available


  361. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Text format     Abstract available


  362. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Text format     Abstract available


  363. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Text format     Abstract available


  364. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Text format     Abstract available


  365. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Text format     Abstract available


  366. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Text format     Abstract available


  367. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Text format     Abstract available


  368. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Text format     Abstract available


  369. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Text format     Abstract available


  370. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Text format     Abstract available


  371. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed     Text format    


  372. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed     Text format    


  373. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Text format     Abstract available


  374. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Text format     Abstract available


  375. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Text format     Abstract available


  376. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Text format     Abstract available


  377. KISTANGARI G, Lopez R, Shen B
    Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:661-671.
    PubMed     Text format     Abstract available


  378. ZUNDLER S, Neurath MF
    Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:617-627.
    PubMed     Text format     Abstract available


  379. SHIYING W, Boyun S, Jianye Y, Wanjun Z, et al
    The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2.
    Inflamm Bowel Dis. 2017;23:603-616.
    PubMed     Text format     Abstract available


  380. SAEED MA, Ng GZ, Dabritz J, Wagner J, et al
    Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.
    Inflamm Bowel Dis. 2017;23:593-602.
    PubMed     Text format     Abstract available


  381. GROSEN A, Kelsen J, Hvas CL, Bellaguarda E, et al
    The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
    Inflamm Bowel Dis. 2017;23:561-569.
    PubMed     Text format     Abstract available


  382. DE JONG M, van der Meulen-de Jong A, Romberg-Camps M, Degens J, et al
    Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
    Inflamm Bowel Dis. 2017;23:485-493.
    PubMed     Text format     Abstract available


  383. HRADSKY O, Soucek O, Maratova K, Matyskova J, et al
    Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD.
    Inflamm Bowel Dis. 2017;23:514-523.
    PubMed     Text format     Abstract available


  384. CHAUDHRY NA, Riverso M, Grajo JR, Moser PP, et al
    A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:641-649.
    PubMed     Text format     Abstract available


  385. SHAH ED, Farida JP, Siegel CA, Chong K, et al
    Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2017;23:570-577.
    PubMed     Text format     Abstract available


  386. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:635-640.
    PubMed     Text format     Abstract available


    March 2017
  387. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Text format     Abstract available


  388. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Text format     Abstract available


  389. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Text format     Abstract available


  390. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Text format     Abstract available


  391. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Text format     Abstract available


  392. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed     Text format    


  393. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed     Text format    


  394. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Text format     Abstract available


  395. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Text format     Abstract available


  396. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Text format     Abstract available


  397. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Text format     Abstract available


  398. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Text format     Abstract available


  399. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Text format     Abstract available


  400. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed     Text format    


  401. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Text format     Abstract available


  402. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Text format     Abstract available


  403. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Text format     Abstract available


  404. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Text format     Abstract available


  405. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Text format     Abstract available


  406. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Text format     Abstract available


  407. TARGOWNIK LE, Tennakoon A, Leung S, Lix LM, et al
    Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:409-420.
    PubMed     Text format     Abstract available


  408. ZUNDLER S, Fischer A, Schillinger D, Binder MT, et al
    The alpha4beta1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
    Inflamm Bowel Dis. 2017;23:379-391.
    PubMed     Text format     Abstract available


  409. CARLSEN K, Haddad N, Gordon J, Phan BL, et al
    Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:341-346.
    PubMed     Text format     Abstract available


  410. SEINEN ML, van Asseldonk DP, de Boer NK, Bouma G, et al
    Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Inflamm Bowel Dis. 2017;23:448-452.
    PubMed     Text format     Abstract available


  411. LOPETUSO LR, Jia R, Wang XM, Jia LG, et al
    Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.
    Inflamm Bowel Dis. 2017;23:392-403.
    PubMed     Text format     Abstract available


  412. COWARD S, Kuenzig ME, Hazlewood G, Clement F, et al
    Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Inflamm Bowel Dis. 2017;23:461-472.
    PubMed     Text format     Abstract available


  413. GHOSH S, Louis E, Beaugerie L, Bossuyt P, et al
    Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:333-340.
    PubMed     Text format     Abstract available


  414. LU C, Gui X, Chen W, Fung T, et al
    Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2017;23:421-430.
    PubMed     Text format     Abstract available


  415. FAUBION WA, Dubinsky M, Ruemmele FM, Escher J, et al
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:453-460.
    PubMed     Text format     Abstract available


  416. HUANG Z, Chao K, Li M, Zhi M, et al
    Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Inflamm Bowel Dis. 2017;23:440-447.
    PubMed     Text format     Abstract available


    February 2017
  417. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Text format     Abstract available


  418. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Text format     Abstract available


  419. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Text format     Abstract available


  420. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Text format     Abstract available


  421. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Text format     Abstract available


  422. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Text format     Abstract available


  423. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Text format     Abstract available


  424. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Text format     Abstract available


  425. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Text format     Abstract available


  426. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Text format     Abstract available


  427. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Text format     Abstract available


  428. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Text format     Abstract available


  429. MAGRO F, Dias CC, Coelho R, Santos PM, et al
    Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
    Inflamm Bowel Dis. 2017;23:289-297.
    PubMed     Text format     Abstract available


  430. ZAYYANI NR, Malaty HM, Graham DY
    Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based Study.
    Inflamm Bowel Dis. 2017;23:304-309.
    PubMed     Text format     Abstract available


  431. DIEDEREN K, de Ridder L, van Rheenen P, Wolters VM, et al
    Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis.
    Inflamm Bowel Dis. 2017;23:272-282.
    PubMed     Text format     Abstract available


  432. VELONIAS G, Conway G, Andrews E, Garber JJ, et al
    Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:283-288.
    PubMed     Text format     Abstract available


  433. LI XH, Sun CH, Mao R, Huang SY, et al
    Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Inflamm Bowel Dis. 2017;23:244-253.
    PubMed     Text format     Abstract available


    January 2017
  434. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Text format     Abstract available


  435. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Text format     Abstract available


  436. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Text format     Abstract available


  437. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Text format     Abstract available


  438. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed     Text format    


  439. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed     Text format    


  440. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Text format     Abstract available


  441. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Text format     Abstract available


  442. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Text format     Abstract available


  443. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Text format     Abstract available


  444. PICORARO J, Winberry G, Siegel CA, El-Matary W, et al
    Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
    Inflamm Bowel Dis. 2017;23:174-180.
    PubMed     Text format     Abstract available


  445. BETTENWORTH D, Gustavsson A, Atreja A, Lopez R, et al
    A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:133-142.
    PubMed     Text format     Abstract available


  446. ROBLIN X, Duru G, Williet N, Del Tedesco E, et al
    Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:126-132.
    PubMed     Text format     Abstract available


  447. GUMIDYALA AP, Plevinsky JM, Poulopoulos N, Kahn SA, et al
    What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD.
    Inflamm Bowel Dis. 2017;23:89-96.
    PubMed     Text format     Abstract available


  448. LIE MR, Kreijne JE, van der Woude CJ
    Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:75-81.
    PubMed     Text format     Abstract available


  449. COELHO R, Ribeiro H, Maconi G
    Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.
    Inflamm Bowel Dis. 2017;23:23-34.
    PubMed     Text format     Abstract available


  450. YARUR AJ, Quintero MA, Jain A, Czul F, et al
    Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:158-164.
    PubMed     Text format     Abstract available


  451. SANDS BE, Sandborn WJ, Van Assche G, Lukas M, et al
    Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.
    Inflamm Bowel Dis. 2017;23:97-106.
    PubMed     Text format     Abstract available


  452. RISPO A, Imperatore N, Testa A, Mainenti P, et al
    Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.
    Inflamm Bowel Dis. 2017;23:143-151.
    PubMed     Text format     Abstract available


  453. SAKURAI T, Kashida H, Komeda Y, Nagai T, et al
    Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer.
    Inflamm Bowel Dis. 2017;23:57-65.
    PubMed     Text format     Abstract available


  454. RAO BB, Click BH, Koutroubakis IE, Ramos Rivers C, et al
    The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.
    Inflamm Bowel Dis. 2017;23:107-115.
    PubMed     Text format     Abstract available


  455. VAN DER SLOOT KW, Joshi AD, Bellavance DR, Gilpin KK, et al
    Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:82-88.
    PubMed     Text format     Abstract available


  456. HOU JK, Gasche C, Drazin NZ, Weaver SA, et al
    Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:35-43.
    PubMed     Text format     Abstract available


  457. HERFARTH HH, Jackson S, Schliebe BG, Martin C, et al
    Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Inflamm Bowel Dis. 2017;23:14-22.
    PubMed     Text format     Abstract available


    December 2016
  458. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Text format     Abstract available


  459. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Text format     Abstract available


  460. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Text format     Abstract available


  461. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Text format     Abstract available


  462. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  463. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  464. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  465. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Text format     Abstract available


    November 2016
  466. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  467. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  468. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  469. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  470. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  471. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed     Text format    


  472. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Text format     Abstract available


  473. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Text format     Abstract available


  474. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Text format     Abstract available


  475. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Text format     Abstract available


  476. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Text format     Abstract available


  477. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  478. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  479. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  480. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  481. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  482. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  483. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  484. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


    May 2016
  485. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Text format     Abstract available


  486. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Text format     Abstract available


  487. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Text format     Abstract available


  488. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Text format     Abstract available


  489. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Text format     Abstract available


  490. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Text format     Abstract available


  491. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Text format     Abstract available


  492. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Text format     Abstract available


  493. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Text format     Abstract available


  494. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Text format     Abstract available


  495. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Text format     Abstract available


  496. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Text format     Abstract available


  497. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Text format     Abstract available


  498. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Text format     Abstract available


  499. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Text format     Abstract available


  500. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Text format     Abstract available


    April 2016
  501. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Text format     Abstract available


  502. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Text format     Abstract available


  503. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Text format     Abstract available


  504. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Text format     Abstract available


  505. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Text format     Abstract available


  506. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Text format     Abstract available


  507. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Text format     Abstract available


    March 2016
  508. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Text format     Abstract available


  509. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed     Text format    


  510. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Text format     Abstract available


  511. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Text format     Abstract available


  512. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Text format     Abstract available


  513. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Text format     Abstract available


  514. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Text format     Abstract available


  515. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Text format     Abstract available


  516. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Text format     Abstract available


    February 2016
  517. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed     Text format    


  518. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Text format     Abstract available


  519. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed     Text format    


  520. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Text format     Abstract available


  521. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Text format     Abstract available


  522. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Text format     Abstract available


  523. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Text format     Abstract available


  524. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Text format     Abstract available


  525. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Text format     Abstract available


  526. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Text format     Abstract available


  527. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Text format     Abstract available


  528. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Text format     Abstract available


  529. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Text format     Abstract available


    January 2016
  530. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Text format     Abstract available


  531. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Text format     Abstract available


  532. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Text format     Abstract available


  533. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Text format     Abstract available


  534. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Text format     Abstract available


  535. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Text format     Abstract available


  536. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Text format     Abstract available


    October 2015
  537. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: